Drug discovery and development partner for major pharmaceutical companies, creating clinical-stage therapeutics for age-related inflammatory and degenerative diseases (cancer-associated inflammation, wet AMD, Alzheimer’s). Pipeline features molecules engineered to safely engage previously "undruggable" targets, aiming for higher efficacy while addressing historic safety concerns.